---
schema_version: "secwatch.filing_event.v1"
accession: "0001625297-25-000069"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2025-11-20T23:59:59+00:00"
generated_at: "2026-05-16T17:59:36.576258+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Indivior pays $295M to DOJ, concludes legacy resolution agreement

## Summary
- Paid $295M in full to DOJ using cash on hand, resolving 2020 Resolution Agreement.
- Resolution Agreement terminated on November 20, 2025.
- CEO Joe Ciaffoni says milestone removes significant liability and simplifies capital structure.
- Company reaffirms commitment to compliance and transparency.

## SEC filing metadata
- accession: 0001625297-25-000069
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2025-11-20T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- confidence: high
- sec_items: 1.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000069/0001625297-25-000069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000069/indv-20251120.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625297-25-000069
- JSON: https://secwatch.observer/filing/0001625297-25-000069.json
- Plain text: https://secwatch.observer/filing/0001625297-25-000069.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.